PLx Pharma Inc.
PLXP · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $386 | $483 | $2,083 | $1,592 |
| % Growth | -20.1% | -76.8% | 30.8% | – |
| Cost of Goods Sold | $1,460 | $820 | $1,169 | $892 |
| Gross Profit | -$1,074 | -$337 | $914 | $700 |
| % Margin | -278.2% | -69.8% | 43.9% | 44% |
| R&D Expenses | $623 | $556 | $654 | $688 |
| G&A Expenses | $0 | $0 | $0 | $2,636 |
| SG&A Expenses | $9,142 | $13,645 | $18,456 | $20,864 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $18,227 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,765 | $14,201 | $19,110 | $21,551 |
| Operating Income | -$10,839 | -$14,538 | -$18,196 | $3,562 |
| % Margin | -2,808% | -3,009.9% | -873.5% | 223.8% |
| Other Income/Exp. Net | $2,342 | $2,680 | $7,411 | $24,414 |
| Pre-Tax Income | -$8,497 | -$11,858 | -$10,785 | $3,562 |
| Tax Expense | -$2,342 | -$2,680 | -$7,411 | $0 |
| Net Income | -$6,155 | -$9,178 | -$3,374 | $3,562 |
| % Margin | -1,594.6% | -1,900.2% | -162% | 223.8% |
| EPS | -0.22 | -0.33 | -0.12 | 0.13 |
| % Growth | 33.3% | -175% | -192.3% | – |
| EPS Diluted | -0.22 | -0.33 | -0.12 | 0.13 |
| Weighted Avg Shares Out | 28,603 | 27,694 | 27,539 | 27,532 |
| Weighted Avg Shares Out Dil | 28,603 | 27,694 | 27,539 | 28,417 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $119 | $29 | $3 | -$9 |
| Depreciation & Amortization | -$2,165 | -$2,602 | -$7,352 | $55 |
| EBITDA | -$13,004 | -$17,140 | -$25,548 | $3,618 |
| % Margin | -3,368.9% | -3,548.7% | -1,226.5% | 227.2% |